A new artificial intelligence predictor is set to tailor abiraterone treatment for prostate cancer patients, by accurately identifying which men will benefit most from this drug that can halve the …
© Copyright by NEWZEALAND WEEKLY (A Digital Media Brand owned by AMAZON MEDIA LLC).